These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 15146935

  • 1. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
    Tanaka J, Iida H, Abe M, Yuda Y, Inoue S, Okabe S.
    Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
    [Abstract] [Full Text] [Related]

  • 2. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

  • 3. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H, Hamada K, Taga F, Nishino K.
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [Abstract] [Full Text] [Related]

  • 7. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M, Isobe Y, Arai I, Hirose-Kijima H, Usuki-Ito C, Nagai H, Aihara H, Otomo S.
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T, Aihara K, Yamada S, Narita S, Kogi K.
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [Abstract] [Full Text] [Related]

  • 9. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
    Ueda F, Aratani S, Mimura K, Kimura K, Nomura A, Enomoto H.
    Arzneimittelforschung; 1984 Feb; 34(4):474-7. PubMed ID: 6540106
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5).
    Sohn SK, Chang MS, Chung YK, Kim KB, Wook TW, Kim SG, Choi WS.
    Arch Pharm Res; 1998 Jun; 21(3):241-7. PubMed ID: 9875438
    [Abstract] [Full Text] [Related]

  • 13. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
    Asano M, Kurebayashi Y, Ryokawa Y, Hashizume T, Akashi A.
    Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
    [Abstract] [Full Text] [Related]

  • 14. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D, Chae JB, Park CW, Kim YS, Lee SM, Kim EJ, Huh IH, Kim DY, Cho KD.
    Arzneimittelforschung; 2001 Mar; 51(3):204-13. PubMed ID: 11304936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP, Garay GL, Baker S, Schuler M, Carter H.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [Abstract] [Full Text] [Related]

  • 18. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
    Tariq M, Parmar NS, Ageel AM.
    J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
    [Abstract] [Full Text] [Related]

  • 19. Effect of a novel xanthine derivative on experimental ulcers in rats.
    Tanaka T, Morioka Y, Gebert U.
    Arzneimittelforschung; 1993 May; 43(5):558-62. PubMed ID: 8329000
    [Abstract] [Full Text] [Related]

  • 20. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M, Sakuma H, Shiratsuchi K, Mieda M.
    Arzneimittelforschung; 1985 May; 35(5):844-8. PubMed ID: 2862875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.